Találati lista | Tudóstér

001-es BibID:	BIBFORM042704
035-os BibID:	PMID:16197494
Első szerző:	Korponay-Szabó Ilma (gyermekgyógyász)
Cím:	Coeliac disease case finding and diet monitoring by point-of-care testing / I. R. Korponay-Szabó, T. Raivio, K. Laurila, J. Opre, R. Király, J. B. Kovács, K. Kaukinen, L. Fésüs, M. Mäki
Dátum:	2005
ISSN:	0269-2813
Megjegyzések:	BACKGROUND: Immunoglobulin A class transglutaminase autoantibodies are highly predictive markers of active coeliac disease, a disorder difficult to recognize solely on clinical grounds. AIMS: To develop and evaluate a simple rapid test for point-of-care detection of coeliac autoantibodies. METHODS: The novel whole blood test utilizes the patient's endogenous transglutaminase in red blood cells for detection of transglutaminase-specific immunoglobulin A antibodies present in the blood sample, with normal plasma immunoglobulin A detection as positive test control. We evaluated 284 patients under suspicion of coeliac disease and undergoing jejunal biopsy, and 263 coeliac patients on a gluten-free diet, 383 being tested prospectively in a point-of-care setting. Results were compared with histology, conventional serum autoantibody results and dietary adherence. RESULTS: The rapid test showed 97% sensitivity and 97% specificity for untreated coeliac disease, and identified all immunoglobulin A-deficient samples. Point-of-care testing found new coeliac cases as efficiently as antibody tests in laboratory. Coeliac autoantibodies were detected onsite in 21% of treated patients, while endomysial and transglutaminase antibodies were positive in 20% and 19%, respectively. The positivity rate correlated with dietary lapses and decreased on intensified dietary advice given upon positive point-of-care test results. CONCLUSIONS: Point-of-care testing was accurate in finding new coeliac cases and helped to identify and decrease dietary non-compliance.
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban egyetemen (Magyarországon) készült közlemény
Megjelenés:	Alimentary Pharmacology and Therapeutics. - 22 : 8 (2005), p. 729-737. -
További szerzők:	Raivio, Tiina Laurila, Kaija Opre Judit (Kenézy Gyula Kórház) Király Róbert (1975-) (biológus) Kovács J. Béla Kaukinen, Katri Fésüs László (1947-) (orvos biokémikus) Mäki, Markku
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM042703
035-os BibID:	PMID:15082580
Első szerző:	Korponay-Szabó Ilma (gyermekgyógyász)
Cím:	In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies / I. R. Korponay-Szabo, T. Halttunen, Z. Szalai, K. Laurila, R. Király, J. B. Kovács, L. Fésüs, M. Mäki
Dátum:	2004
ISSN:	0017-5749
Megjegyzések:	BACKGROUND: IgA class serum autoantibodies against type 2 (tissue) transglutaminase (TG2) bind to both intestinal and extraintestinal normal tissue sections in vitro, eliciting endomysial, reticulin, and jejunal antibody reactions. It is not known whether similar binding also occurs in coeliac patients in vivo, and may thereby contribute to disease manifestations. AIMS: To investigate intestinal and extraintestinal coeliac tissues for the presence of in vivo bound TG2 specific IgA and its relation to small intestinal mucosal atrophy. PATIENTS: We investigated jejunal samples with normal villous morphology from 10 patients with developing coeliac disease who subsequently progressed to a flat lesion, from 11 patients with dermatitis herpetiformis, and from 12 non-coeliac controls. Six extrajejunal biopsy samples (liver, lymph node, muscle, appendix), obtained based on independent clinical indications from patients with active coeliac disease, were also studied. METHODS: Double colour immunofluorescent studies for in situ IgA, TG2, and laminin were performed. IgA was eluted from tissue sections and tested for TG2 specificity by enzyme linked immunosorbent assay and indirect immunofluorescence. RESULTS: IgA (in one IgA deficient case IgG) deposition on extracellularly located TG2 was detected in jejunal and extrajejunal specimens of all coeliac patients, and also in seven of 11 dermatitis herpetiformis patients, of whom two had no circulating endomysial antibodies. IgA eluted from extraintestinal coeliac tissues was targeted against TG2. CONCLUSIONS: Coeliac IgA targets jejunal TG2 early in disease development even when endomysial antibodies are not present in the circulation. Extraintestinal target sites of coeliac IgA further indicate that humoral immunity may have a pathogenetic role.
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban egyetemen (Magyarországon) készült közlemény
Megjelenés:	Gut. - 53 : 5 (2004), p. 641-648. -
További szerzők:	Halttunen, Tuula Szalai Zoltán Laurila, Kaija Király Róbert (1975-) (biológus) Kovács J. Béla Fésüs László (1947-) (orvos biokémikus) Mäki, Markku
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: